Title: 2025-2026 Regular Session SB 95 PN 0918 Bill Text (HTM)
Official Title: 
Number of Sections: 1
Source: versions - Printer's No. PN0918
Media Type: text/html

================================================================================

Section 1:
2025-2026 Regular Session SB 95 PN 0918 Bill Text (HTM) See other bills under thesame topic PRIOR PRINTER'S NO. 50PRINTER'S NO. 918THE GENERAL ASSEMBLY OF PENNSYLVANIASENATE BILL No.95 Session of 2025 INTRODUCED BY PHILLIPS-HILL, BROOKS, STREET, FONTANA, COMITTA, ROTHMAN, ROBINSON, TARTAGLIONE, COSTA, KANE, HAYWOOD, BAKER, J. WARD, STEFANO, SAVAL, YAW, MASTRIANO, FARRY AND DUSH, JANUARY 22, 2025 AS AMENDED ON THIRD CONSIDERATION, JUNE 9, 2025AN ACTAmending the act of September 27, 1961 (P.L.1700, No.699), entitled "An act relating to the regulation of the practice of pharmacy, including the sales, use and distribution of drugs and devices at retail; and amending, revising, consolidating and repealing certain laws relating thereto," further providing for definitions and for unlawful acts; AND PROVIDING FOR PRICE DISCLOSURE.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. Section 2 of the act of September 27, 1961 (P.L.1700, No.699), known as the Pharmacy Act, is amended by adding clauses to read:Section 2. Definitions.--As used in this act:* * *(24) "EMS provider" means "emergency medical services provider" or "EMS provider" as defined in 35 Pa.C.S. § 8103 (relating to definitions).(25) "Dose package" means an individually sealed package that contains naloxone or another comparable treatment regimen <--12345678910111213141516171819 as determined by the Secretary of Health in a standing order to be used for the reversal of a single opioid-related overdose event.Section 2. Section 8(2) of the act is amended and the section is amended by adding a clause to read:Section 8. Unlawful Acts.--It shall be unlawful for:* * *(2) [Any] Except as provided in clause (2.2), any person not duly licensed as a pharmacist, pursuant to section 3 hereof, to engage in the practice of pharmacy, including the preparing, compounding, dispensing, selling or distributing at retail to any person any drug, except by a pharmacy intern or such other authorized personnel under the direct and immediate personal supervision of a pharmacist: Provided, however, That nothing herein shall be construed to prevent a duly licensed medical practitioner from dispensing, compounding or otherwise giving any drug to his own patients after diagnosis or treatment of said patient, if such compounding, preparing and dispensing is done by said licensee himself, nor shall anything herein prevent any person from selling or distributing at retail household remedies or proprietary medicines when the same are offered for sale or sold in the original packages which have been put up ready for sale to consumers, provided household remedies or proprietary medicines shall not include any controlled substances or non-proprietary drug under the act of April 14, 1972 (P.L.233, No.64), known as "The Controlled Substance, Drug, Device and Cosmetic Act."* * *(2.2) An EMS provider to dispense a dose package unless all of the following apply:20250SB0095PN0918 - 2 - 123456789101112131415161718192021222324252627282930 (i) A standing order issued by the Secretary of Health allows for the purchase of naloxone or a dose package by the public without a prescription.(ii) The EMS provider determines that it is appropriate to dispense a dose package to a family member, a friend or another individual who is in a position to assist a patient who has experienced an opioid-related overdose event, based on the immediate circumstances surrounding the event or other conditions, including the availability and accessibility of a pharmacy. The dispensing of the dose package shall be voluntary on the part of the EMS provider. The following shall apply:(A) This subclause shall not create any obligation on the part of an EMS provider to stock the dose package or dispense the dose package to the family member, friend or other individual.(B) The EMS provider shall not incur any liability for not stocking the dose package or not dispensing the dose package to the family member, friend or other individual.(iii) The EMS provider enters the date and contents of the dose package under subclause (ii) on the back of the dose package or on another appropriate, uniformly maintained and readily retrievable record. The EMS provider shall also sign the dose package or record.(iv) The EMS provider provides only one dose package under subclause (ii) and the quantity of that dose package is in conformity with the prescribed directions for use.* * *Section 3. This act shall take effect in 60 days.SECTION 3. THE ACT IS AMENDED BY ADDING A SECTION TO READ:SECTION 9.6. PRICE DISCLOSURE.--(A) FOR EVERY PRESCRIPTION 20250SB0095PN0918 - 3 - <--<--123456789101112131415161718192021222324252627282930 MEDICATION THAT A CONSUMER INTENDS TO PURCHASE, A PHARMACY OR AN AUTHORIZED EMPLOYE OF THE PHARMACY SHALL, UPON REQUEST, DISCLOSE THE FOLLOWING:(1) THE CURRENT PHARMACY RETAIL PRICE OF THE BRAND-NAME DRUG AND ANY GENERICALLY EQUIVALENT DRUG AVAILABLE AT THE PHARMACY, WHERE APPLICABLE.(2) THE CONSUMER'S COST-SHARING AMOUNT OF THE BRAND-NAME DRUG AND ANY GENERICALLY EQUIVALENT DRUG AVAILABLE AT THE PHARMACY, WHERE APPLICABLE.(3) INFORMATION ON WHERE TO APPLY FOR SUBSIDIZED HEALTH COVERAGE THROUGH THE COMMONWEALTH'S OFFICIAL HEALTH INSURANCE EXCHANGE, USING MATERIALS DEVELOPED BY THE EXCHANGE AUTHORITY, WHICH SHALL BE MADE AVAILABLE ON THE EXCHANGE AUTHORITY'S PUBLICLY ACCESSIBLE INTERNET WEBSITE AND SHARED WITH THE BOARD.(4) A DISCLAIMER, WHICH SHALL BE INCLUDED WITH THE INFORMATION REQUIRED UNDER THIS SECTION. THE DISCLAIMER SHALL STATE: "A CONSUMER'S HEALTH CARE CHOICES, INCLUDING WHETHER A PARTICULAR ON-EXCHANGE HEALTH INSURANCE POLICY IS APPROPRIATE FOR THE CONSUMER, SHOULD NOT BE BASED SOLELY ON THE INFORMATION PROVIDED, BUT SHOULD INSTEAD BE CONSIDERED IN CONNECTION WITH THE CONSUMER'S OTHER HEALTH CARE AND FINANCIAL CIRCUMSTANCES."(B) A PHARMACY SHALL BE REQUIRED TO KEEP AN ELECTRONIC OR PAPER COPY OF THIS SECTION, INCLUDING ANY RULES AND REGULATIONS ISSUED UNDER THIS SECTION, ON FILE. A PHARMACY SHALL POST IN A CONSPICUOUS MANNER AT ALL LOCATIONS WHERE PRESCRIPTION MEDICATIONS ARE SOLD A NOTICE INFORMING THE CONSUMER OF THE RIGHT TO REQUEST DISCLOSURES PROVIDED FOR UNDER THIS SECTION. THE BOARD SHALL NOTIFY EACH PHARMACY OF ANY CHANGE TO THIS SECTION AND ANY CHANGE TO RULES AND REGULATIONS ISSUED UNDER THIS SECTION. A PHARMACY SHALL HAVE THIRTY DAYS TO UPDATE THE 20250SB0095PN0918 - 4 - 123456789101112131415161718192021222324252627282930 COPY AND NOTICE FROM THE DATE THE PHARMACY WAS NOTIFIED BY THE BOARD OF A CHANGE. THE BOARD SHALL FURNISH EACH PHARMACY WITH A COPY OF THIS SECTION, ANY RULES AND REGULATIONS ISSUED UNDER THIS SECTION AND THE NOTICE AS REQUIRED UNDER THIS SUBSECTION.(C) THE NOTICE AND DISCLOSURE REQUIRED UNDER THIS SECTION SHALL BE PRESENTED IN A MANNER THAT IS SIMPLE AND EASY TO UNDERSTAND.(D) A PHARMACY, PHARMACY BENEFITS MANAGER OR HEALTH INSURER THAT FAILS TO COMPLY WITH THE REQUIREMENTS OF THIS SECTION COMMITS A SUMMARY OFFENSE AND, UPON CONVICTION, SHALL BE SENTENCED TO PAY A FINE OF NOT MORE THAN FIVE HUNDRED DOLLARS ($500). THIS SUBSECTION SHALL NOT APPLY TO A PHARMACY FOR FAILURE TO DISCLOSE THE INFORMATION IN SUBSECTION (A), UPON REQUEST, DUE TO TECHNOLOGICAL ISSUES.(E) THE BOARD, IN CONSULTATION WITH THE EXCHANGE AUTHORITY AND INSURANCE DEPARTMENT, AS APPROPRIATE, SHALL ADOPT RULES AND REGULATIONS AS NECESSARY TO CARRY OUT AND ENFORCE THIS SECTION.(F) AS USED IN THIS SECTION, THE FOLLOWING WORDS AND PHRASES SHALL HAVE THE MEANINGS GIVEN TO THEM IN THIS SUBSECTION UNLESS THE CONTEXT CLEARLY INDICATES OTHERWISE:(1) "COST-SHARING AMOUNT" MEANS THE AMOUNT OWED BY A POLICYHOLDER UNDER THE TERMS OF THE POLICYHOLDER'S HEALTH INSURANCE POLICY OR AS REQUIRED BY A PHARMACY BENEFITS MANAGER.(2) "EXCHANGE AUTHORITY" MEANS THE PENNSYLVANIA HEALTH INSURANCE EXCHANGE AUTHORITY ESTABLISHED UNDER 40 PA.C.S. § 9302 (RELATING TO PENNSYLVANIA HEALTH INSURANCE EXCHANGE AUTHORITY).(3) "GENERICALLY EQUIVALENT DRUG" MEANS THE TERM AS DEFINED UNDER SECTION 2 OF THE ACT OF NOVEMBER 24, 1976 (P.L.1163, NO.259), REFERRED TO AS THE GENERIC EQUIVALENT DRUG LAW.(4) "HEALTH INSURANCE POLICY" MEANS THE TERM AS DEFINED IN 20250SB0095PN0918 - 5 - 123456789101112131415161718192021222324252627282930 40 PA.C.S. § 9103 (RELATING TO DEFINITIONS).(5) "ON-EXCHANGE HEALTH INSURANCE POLICY" MEANS A HEALTH INSURANCE POLICY OFFERED FOR PURCHASE THROUGH THE HEALTH INSURANCE EXCHANGE OF THE COMMONWEALTH OPERATED BY THE EXCHANGE AUTHORITY.(6) "PHARMACY BENEFITS MANAGER" MEANS THE TERM AS DEFINED UNDER SECTION 103 OF THE ACT OF NOVEMBER 21, 2016 (P.L.1318, NO.169), KNOWN AS THE "PHARMACY AUDIT INTEGRITY AND TRANSPARENCY ACT."(7) "PHARMACY RETAIL PRICE" MEANS THE PRICE THAT AN INDIVIDUAL WITHOUT PRESCRIPTION DRUG COVERAGE OR NOT USING ANY OTHER PRESCRIPTION MEDICATION BENEFIT OR DISCOUNT WOULD PAY AT A RETAIL PHARMACY, NOT INCLUDING A PHARMACIST DISPENSING FEE.SECTION 4. THIS ACT SHALL TAKE EFFECT AS FOLLOWS:(1) THE FOLLOWING SHALL TAKE EFFECT IMMEDIATELY:THE ADDITION OF SECTION 9.6(E) AND (F) OF THE ACT.THIS SECTION.(2) THE AMENDMENT OF SECTIONS 2 AND 8 OF THE ACT SHALL TAKE EFFECT IN 60 DAYS.(3) THE REMAINDER OF THIS ACT SHALL TAKE EFFECT IN ONE YEAR.20250SB0095PN0918 - 6 - 123456789101112131415161718192021


================================================================================

Raw Text:
2025-2026 Regular Session SB 95 PN 0918 Bill Text (HTM) See other bills under thesame topic PRIOR PRINTER'S NO. 50PRINTER'S NO. 918THE GENERAL ASSEMBLY OF PENNSYLVANIASENATE BILL No.95 Session of 2025 INTRODUCED BY PHILLIPS-HILL, BROOKS, STREET, FONTANA, COMITTA, ROTHMAN, ROBINSON, TARTAGLIONE, COSTA, KANE, HAYWOOD, BAKER, J. WARD, STEFANO, SAVAL, YAW, MASTRIANO, FARRY AND DUSH, JANUARY 22, 2025 AS AMENDED ON THIRD CONSIDERATION, JUNE 9, 2025AN ACTAmending the act of September 27, 1961 (P.L.1700, No.699), entitled "An act relating to the regulation of the practice of pharmacy, including the sales, use and distribution of drugs and devices at retail; and amending, revising, consolidating and repealing certain laws relating thereto," further providing for definitions and for unlawful acts; AND PROVIDING FOR PRICE DISCLOSURE.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. Section 2 of the act of September 27, 1961 (P.L.1700, No.699), known as the Pharmacy Act, is amended by adding clauses to read:Section 2. Definitions.--As used in this act:* * *(24) "EMS provider" means "emergency medical services provider" or "EMS provider" as defined in 35 Pa.C.S. § 8103 (relating to definitions).(25) "Dose package" means an individually sealed package that contains naloxone or another comparable treatment regimen <--12345678910111213141516171819 as determined by the Secretary of Health in a standing order to be used for the reversal of a single opioid-related overdose event.Section 2. Section 8(2) of the act is amended and the section is amended by adding a clause to read:Section 8. Unlawful Acts.--It shall be unlawful for:* * *(2) [Any] Except as provided in clause (2.2), any person not duly licensed as a pharmacist, pursuant to section 3 hereof, to engage in the practice of pharmacy, including the preparing, compounding, dispensing, selling or distributing at retail to any person any drug, except by a pharmacy intern or such other authorized personnel under the direct and immediate personal supervision of a pharmacist: Provided, however, That nothing herein shall be construed to prevent a duly licensed medical practitioner from dispensing, compounding or otherwise giving any drug to his own patients after diagnosis or treatment of said patient, if such compounding, preparing and dispensing is done by said licensee himself, nor shall anything herein prevent any person from selling or distributing at retail household remedies or proprietary medicines when the same are offered for sale or sold in the original packages which have been put up ready for sale to consumers, provided household remedies or proprietary medicines shall not include any controlled substances or non-proprietary drug under the act of April 14, 1972 (P.L.233, No.64), known as "The Controlled Substance, Drug, Device and Cosmetic Act."* * *(2.2) An EMS provider to dispense a dose package unless all of the following apply:20250SB0095PN0918 - 2 - 123456789101112131415161718192021222324252627282930 (i) A standing order issued by the Secretary of Health allows for the purchase of naloxone or a dose package by the public without a prescription.(ii) The EMS provider determines that it is appropriate to dispense a dose package to a family member, a friend or another individual who is in a position to assist a patient who has experienced an opioid-related overdose event, based on the immediate circumstances surrounding the event or other conditions, including the availability and accessibility of a pharmacy. The dispensing of the dose package shall be voluntary on the part of the EMS provider. The following shall apply:(A) This subclause shall not create any obligation on the part of an EMS provider to stock the dose package or dispense the dose package to the family member, friend or other individual.(B) The EMS provider shall not incur any liability for not stocking the dose package or not dispensing the dose package to the family member, friend or other individual.(iii) The EMS provider enters the date and contents of the dose package under subclause (ii) on the back of the dose package or on another appropriate, uniformly maintained and readily retrievable record. The EMS provider shall also sign the dose package or record.(iv) The EMS provider provides only one dose package under subclause (ii) and the quantity of that dose package is in conformity with the prescribed directions for use.* * *Section 3. This act shall take effect in 60 days.SECTION 3. THE ACT IS AMENDED BY ADDING A SECTION TO READ:SECTION 9.6. PRICE DISCLOSURE.--(A) FOR EVERY PRESCRIPTION 20250SB0095PN0918 - 3 - <--<--123456789101112131415161718192021222324252627282930 MEDICATION THAT A CONSUMER INTENDS TO PURCHASE, A PHARMACY OR AN AUTHORIZED EMPLOYE OF THE PHARMACY SHALL, UPON REQUEST, DISCLOSE THE FOLLOWING:(1) THE CURRENT PHARMACY RETAIL PRICE OF THE BRAND-NAME DRUG AND ANY GENERICALLY EQUIVALENT DRUG AVAILABLE AT THE PHARMACY, WHERE APPLICABLE.(2) THE CONSUMER'S COST-SHARING AMOUNT OF THE BRAND-NAME DRUG AND ANY GENERICALLY EQUIVALENT DRUG AVAILABLE AT THE PHARMACY, WHERE APPLICABLE.(3) INFORMATION ON WHERE TO APPLY FOR SUBSIDIZED HEALTH COVERAGE THROUGH THE COMMONWEALTH'S OFFICIAL HEALTH INSURANCE EXCHANGE, USING MATERIALS DEVELOPED BY THE EXCHANGE AUTHORITY, WHICH SHALL BE MADE AVAILABLE ON THE EXCHANGE AUTHORITY'S PUBLICLY ACCESSIBLE INTERNET WEBSITE AND SHARED WITH THE BOARD.(4) A DISCLAIMER, WHICH SHALL BE INCLUDED WITH THE INFORMATION REQUIRED UNDER THIS SECTION. THE DISCLAIMER SHALL STATE: "A CONSUMER'S HEALTH CARE CHOICES, INCLUDING WHETHER A PARTICULAR ON-EXCHANGE HEALTH INSURANCE POLICY IS APPROPRIATE FOR THE CONSUMER, SHOULD NOT BE BASED SOLELY ON THE INFORMATION PROVIDED, BUT SHOULD INSTEAD BE CONSIDERED IN CONNECTION WITH THE CONSUMER'S OTHER HEALTH CARE AND FINANCIAL CIRCUMSTANCES."(B) A PHARMACY SHALL BE REQUIRED TO KEEP AN ELECTRONIC OR PAPER COPY OF THIS SECTION, INCLUDING ANY RULES AND REGULATIONS ISSUED UNDER THIS SECTION, ON FILE. A PHARMACY SHALL POST IN A CONSPICUOUS MANNER AT ALL LOCATIONS WHERE PRESCRIPTION MEDICATIONS ARE SOLD A NOTICE INFORMING THE CONSUMER OF THE RIGHT TO REQUEST DISCLOSURES PROVIDED FOR UNDER THIS SECTION. THE BOARD SHALL NOTIFY EACH PHARMACY OF ANY CHANGE TO THIS SECTION AND ANY CHANGE TO RULES AND REGULATIONS ISSUED UNDER THIS SECTION. A PHARMACY SHALL HAVE THIRTY DAYS TO UPDATE THE 20250SB0095PN0918 - 4 - 123456789101112131415161718192021222324252627282930 COPY AND NOTICE FROM THE DATE THE PHARMACY WAS NOTIFIED BY THE BOARD OF A CHANGE. THE BOARD SHALL FURNISH EACH PHARMACY WITH A COPY OF THIS SECTION, ANY RULES AND REGULATIONS ISSUED UNDER THIS SECTION AND THE NOTICE AS REQUIRED UNDER THIS SUBSECTION.(C) THE NOTICE AND DISCLOSURE REQUIRED UNDER THIS SECTION SHALL BE PRESENTED IN A MANNER THAT IS SIMPLE AND EASY TO UNDERSTAND.(D) A PHARMACY, PHARMACY BENEFITS MANAGER OR HEALTH INSURER THAT FAILS TO COMPLY WITH THE REQUIREMENTS OF THIS SECTION COMMITS A SUMMARY OFFENSE AND, UPON CONVICTION, SHALL BE SENTENCED TO PAY A FINE OF NOT MORE THAN FIVE HUNDRED DOLLARS ($500). THIS SUBSECTION SHALL NOT APPLY TO A PHARMACY FOR FAILURE TO DISCLOSE THE INFORMATION IN SUBSECTION (A), UPON REQUEST, DUE TO TECHNOLOGICAL ISSUES.(E) THE BOARD, IN CONSULTATION WITH THE EXCHANGE AUTHORITY AND INSURANCE DEPARTMENT, AS APPROPRIATE, SHALL ADOPT RULES AND REGULATIONS AS NECESSARY TO CARRY OUT AND ENFORCE THIS SECTION.(F) AS USED IN THIS SECTION, THE FOLLOWING WORDS AND PHRASES SHALL HAVE THE MEANINGS GIVEN TO THEM IN THIS SUBSECTION UNLESS THE CONTEXT CLEARLY INDICATES OTHERWISE:(1) "COST-SHARING AMOUNT" MEANS THE AMOUNT OWED BY A POLICYHOLDER UNDER THE TERMS OF THE POLICYHOLDER'S HEALTH INSURANCE POLICY OR AS REQUIRED BY A PHARMACY BENEFITS MANAGER.(2) "EXCHANGE AUTHORITY" MEANS THE PENNSYLVANIA HEALTH INSURANCE EXCHANGE AUTHORITY ESTABLISHED UNDER 40 PA.C.S. § 9302 (RELATING TO PENNSYLVANIA HEALTH INSURANCE EXCHANGE AUTHORITY).(3) "GENERICALLY EQUIVALENT DRUG" MEANS THE TERM AS DEFINED UNDER SECTION 2 OF THE ACT OF NOVEMBER 24, 1976 (P.L.1163, NO.259), REFERRED TO AS THE GENERIC EQUIVALENT DRUG LAW.(4) "HEALTH INSURANCE POLICY" MEANS THE TERM AS DEFINED IN 20250SB0095PN0918 - 5 - 123456789101112131415161718192021222324252627282930 40 PA.C.S. § 9103 (RELATING TO DEFINITIONS).(5) "ON-EXCHANGE HEALTH INSURANCE POLICY" MEANS A HEALTH INSURANCE POLICY OFFERED FOR PURCHASE THROUGH THE HEALTH INSURANCE EXCHANGE OF THE COMMONWEALTH OPERATED BY THE EXCHANGE AUTHORITY.(6) "PHARMACY BENEFITS MANAGER" MEANS THE TERM AS DEFINED UNDER SECTION 103 OF THE ACT OF NOVEMBER 21, 2016 (P.L.1318, NO.169), KNOWN AS THE "PHARMACY AUDIT INTEGRITY AND TRANSPARENCY ACT."(7) "PHARMACY RETAIL PRICE" MEANS THE PRICE THAT AN INDIVIDUAL WITHOUT PRESCRIPTION DRUG COVERAGE OR NOT USING ANY OTHER PRESCRIPTION MEDICATION BENEFIT OR DISCOUNT WOULD PAY AT A RETAIL PHARMACY, NOT INCLUDING A PHARMACIST DISPENSING FEE.SECTION 4. THIS ACT SHALL TAKE EFFECT AS FOLLOWS:(1) THE FOLLOWING SHALL TAKE EFFECT IMMEDIATELY:THE ADDITION OF SECTION 9.6(E) AND (F) OF THE ACT.THIS SECTION.(2) THE AMENDMENT OF SECTIONS 2 AND 8 OF THE ACT SHALL TAKE EFFECT IN 60 DAYS.(3) THE REMAINDER OF THIS ACT SHALL TAKE EFFECT IN ONE YEAR.20250SB0095PN0918 - 6 - 123456789101112131415161718192021